# FDA Inspection 1220683 - Mirum Pharmaceuticals, Inc. - October 03, 2023

Source: https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/d318e671-4bc3-4e71-afb8-2dec8ab97c9b
Source feed: FDA_Inspections

> FDA Inspection 1220683 for Mirum Pharmaceuticals, Inc. on October 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220683
- Company Name: Mirum Pharmaceuticals, Inc.
- Inspection Date: 2023-10-03
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259153 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/6e651f6b-bf5a-442a-a9e3-52671438a5ec)
- [FDA Inspection 1259153 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/62d07b12-1f93-429a-b15b-c2c2460ae595)
- [FDA Inspection 1142794 - 2021-05-12](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/bfdc931b-8231-4a10-a274-0a50f91766e7)

Company: https://www.keypedia.com/companies/mirum-pharmaceuticals-inc/9b906e94-ef88-467f-8b15-9f0b02d9e49d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c